echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Directly at the scene of the 2021 CSCO Academic Annual Conference: The compliance rate of CSCO AI and tumor guidelines is as high as 95.8%

    Directly at the scene of the 2021 CSCO Academic Annual Conference: The compliance rate of CSCO AI and tumor guidelines is as high as 95.8%

    • Last Update: 2021-10-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    (Health Times reporter Wang Zhenya) "The third-phase clinical results show that the Chinese artificial intelligence system CSCO AI has a compliance rate of 95.



    Artificial Intelligence in China: Chinese solutions to solve China's clinical pain points

    Hospitals at all levels from across the country, including Anhui, Beijing, Hunan, and Zhejiang, shared the clinical application of CSCO AI (CSCO Artificial Intelligence Assistant Decision System) this year


    "Artificial intelligence is a good assistant for doctors


    In 2018, the Chinese version of oncologist-CSCO AI, based on the Chinese Cancer Treatment Guidelines, came into being


    "The over 95% compliance rate data shows that the artificial intelligence system we made is feasible and credible


    Comparison of clinical treatment benefits: AI smoothes regional treatment differences

    Comparison of clinical treatment benefits: AI smoothes regional treatment differences

    Since the launch of CSCO AI in early 2019, it has been clinically used in nearly 150 hospitals in 21 provinces across the country


    Professor Zhang Suzhan, director of the Cancer Center of the Second Affiliated Hospital of Zhejiang University School of Medicine, believes that the improvement of the survival rate of cancer in China depends on the standardization of tumor treatment.


    Zhang Suzhan believes that artificial intelligence will assist grassroots doctors in making decisions, making judgments, and making standardized tumor diagnosis and treatment


    “It does not require manual input by the doctor.


    "Through the treatment of CSCO AI, we can retain more cancer patients at the grassroots level


    According to Yin Zhen, a doctor of the Dong nationality from Huaihua Cancer Hospital, Hunan Province, as of September 22, 2021, we have a total of 69 artificial intelligence diagnosis and treatment plan reports.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.